AdBio partners
AdBio partners is a venture capital fund supported in particular by the National Seed-Fund.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed AdBio partners Information
Geographic Data
Address: 4 rue Thnard
City: Paris
State: île-de-france
Zip: 75005
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
8,605,059Website Global Rank
100Website Monthly Traffic
Twitter Followers
Description
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward. We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success. We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2019 | Augustine Therapeutics | Seed Round | 4.7M |
| 6/2019 | Yukin Therapeutics | Venture Round | 3.7M |
| 7/2020 | ARTHEx Biotech | Seed Round | 5M |
| 9/2021 | Ribonexus | Seed Round | 0 |
| 6/2019 | Tridek-One | Venture Round | 3.4M |
| 3/2020 | Wellium | Venture Round | 2.2M |
| 1/2020 | Alderaan Biotechnology | Series A | 20.6M |
| 1/2017 | Alderaan Biotechnology | Seed Round | 1.6M |
| 11/2019 | Urania Therapeutics | Seed Round | 0 |
| 5/2023 | ARTHEx Biotech | Series B | 0 |
| 9/2022 | Tridek-One | Venture Round | 0 |
| 5/2023 | DiogenX | Series A | 0 |
| 1/2021 | Thabor Therapeutics | Seed Round | - |
| 4/2019 | AgomAb Therapeutics | Series A | 23.6M |
| 6/2020 | DiogenX | Seed Round | 5.1M |
| 12/2021 | Integra Therapeutics | Seed Round | 0 |
| 6/2023 | Astraveus | Seed Round | 0 |
| 6/2023 | Anoat Therapeutics | Seed Round | 0 |
| 4/2023 | Calida Therapeutics | Seed Round | 0 |
| 10/2022 | Univercells | Series D | 0 |
| 3/2021 | AgomAb Therapeutics | Series B | 0 |
| 6/2023 | Astraveus | Seed Round | 0 |
| 6/2023 | Anoat Therapeutics | Seed Round | 0 |
| 5/2023 | DiogenX | Series A | 0 |
| 5/2023 | ARTHEx Biotech | Series B | 0 |
| 4/2023 | Calida Therapeutics | Seed Round | 0 |
| 10/2022 | Univercells | Series D | 0 |
| 9/2022 | Tridek-One | Venture Round | 0 |
| 12/2021 | Integra Therapeutics | Seed Round | 0 |
| 9/2021 | Ribonexus | Seed Round | 0 |
| 3/2021 | AgomAb Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
